Navigation Links
PDL BioPharma Acquires Portfolio of Diabetes Royalty Rights and Milestones from Depomed
Date:10/21/2013

numet XR in the United States and other licensed territories through the expiration of the licensed patents pursuant to Depomed's license arrangement with Merck.

PDL also acquired certain rights to royalties and milestones on products currently in development by Boehringer Ingelheim and Janssen Pharmaceutica. Boehringer Ingelheim has worldwide rights to Depomed's Acuform® delivery technology for the development and commercialization of certain fixed dose combination products which include extended release metformin and proprietary Boehringer Ingelheim compounds currently in development for type 2 diabetes. Subject to clinical development and product approval, PDL may receive Depomed's milestone payments based on regulatory filings and approval events, as well as royalties on worldwide net sales of products sold by Boehringer Ingelheim. Janssen Pharmaceutica has worldwide rights to Acuform delivery technology for the development and commercialization of a fixed dose combination formulation of Janssen's type 2 diabetes product candidate, Invokana (canagliflozin), a Sodium Glucose Transport 2 (SGLT2) inhibitor, and extended-release metformin. Subject to clinical development and product approval, PDL may receive Depomed's milestone payments and royalties on worldwide net sales of products sold by Janssen under the Depomed license.

About PDL BioPharma

PDL BioPharma manages a portfolio of patents and royalty assets, consisting primarily of its Queen et al. antibody humanization patents and license agreements with various biotechnology and pharmaceutical companies. PDL pioneered the humanization of monoclonal antibodies and, by doing so, enabled the discovery of a new generation of targeted treatments for cancer and immunologic diseases for which it receives significant royalty revenue. PDL is currently focused on intellectual property asset management, investing in new income generating assets, and
'/>"/>

SOURCE PDL BioPharma, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. PDL BioPharma Provides $60 Million in Financing to LENSAR
2. Global Biopharma Mergers & Acquisition and Deal Making Report 2013: Understanding the Latest Trends to Optimize Future Strategy
3. PDL BioPharma to Present at the 4th Annual Credit Suisse Small/Mid Cap Conference
4. PDL BioPharma Provides Third Quarter 2013 Revenue Guidance of $97 Million
5. Market Research Reports: Biologics, Biosimilars, Bioseparation Systems for Biopharmaceutical Markets
6. New HAE Drug Candidate from Dyax Produced by Laureate Biopharma
7. Morning Research: BioCryst Pharma Inc., Questcor Pharma Inc., PDL BioPharma Inc., and Amgen Inc.
8. Robbins Arroyo LLP Is Investigating the Directors and Officers of Navidea Biopharmaceuticals, Inc.
9. PDL BioPharma Announces Second Quarter 2013 Financial Results
10. Pre-Market Analysis: MannKind, Galena Biopharma, Ariad Pharma, and Novavax
11. Array BioPharma To Report Financial Results For The Fourth Quarter And Full Year Of Fiscal 2013 On August 7, 2013
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/23/2014)... July 23, 2014  ArmaGen, a privately held ... treat severe neurological disorders, announced today that it ... agreement with Shire plc to develop AGT-182, an ... of both the central nervous system (CNS) and ... as MPS II, Hunter syndrome is a rare, ...
(Date:7/23/2014)... -- Sinovac Biotech Ltd. (NASDAQ: SVA ), a ... , announced today that it has been selected by the ... be a supplier of the seasonal influenza vaccine to the ... The Beijing CDC plans to order a minimum of ... from four domestic vaccine manufacturers for its vaccination campaign. Each ...
(Date:7/23/2014)... , Indien, July 23, 2014 ... scope für Arbeiten für Sadara Chemical Company ... Engineering Information System innerhalb des integrierten Chemiekomplexes ... award of additional scope im Wert von ... zuvor abgeschlossenen Vertrags dar, dessen Wert sich ...
Breaking Medicine Technology:ArmaGen Announces Strategic Licensing and Collaboration Agreement with Shire to Develop AGT-182 for Treatment of Hunter Syndrome 2ArmaGen Announces Strategic Licensing and Collaboration Agreement with Shire to Develop AGT-182 for Treatment of Hunter Syndrome 3Sinovac Receives Beijing CDC Tender to Supply Seasonal Flu Vaccine Anflu 2Rolta gewinnt Follow-on Award für Engineering Systems für Sadara, Saudi-Arabien im Wert von mehreren Millionen Dollar 2Rolta gewinnt Follow-on Award für Engineering Systems für Sadara, Saudi-Arabien im Wert von mehreren Millionen Dollar 3Rolta gewinnt Follow-on Award für Engineering Systems für Sadara, Saudi-Arabien im Wert von mehreren Millionen Dollar 4
... WASHINGTON, Aug. 17 The American Pharmacists Association (APhA) ... to consider their local pharmacy as the site to ... the District of Columbia are authorized to administer influenza ... 120,000 U.S. pharmacists have been trained to administer immunizations. ...
... 17 Varian Medical Systems, Inc. (NYSE: ... technology on its Trilogy® machine with advanced motion management ... Beijing August 19-21 by China,s Ministry of Health.  Varian, ... cancer and a premier supplier of X-ray imaging technology, ...
Cached Medicine Technology:Consumers Encouraged to Get Immunized Against Influenza 2Varian Medical Systems to Showcase Advanced Motion Management Technology for the Treatment of Lung Cancer at CHINA-HOSPEQ 2010 2Varian Medical Systems to Showcase Advanced Motion Management Technology for the Treatment of Lung Cancer at CHINA-HOSPEQ 2010 3
(Date:7/23/2014)... The European Vitamins Market report explains and divides ... of revenue. The market in Europe is estimated to ... million by 2018, at a CAGR of 6.8% from ... the European Vitamins Market report, to get an idea ... glimpse of the segmentation in the European market, and ...
(Date:7/23/2014)... The European Bio fertilizers Market Report defines and ... and forecast of revenue. The bio fertilizers market in ... million in 2012 to $4,582.2 million by 2017, at ... Browse through the TOC of the European Bio fertilizers ... analysis provided. , http://www.micromarketmonitor.com/market/europe-bio-fertilizer-4637178345.html , The ...
(Date:7/23/2014)... MD (July 23, 2014) Statins, a class of ... a patient,s risk of developing Barrett,s esophagus, according to ... , the official journal of the American Gastroenterological ... reduction with statin use. , "Patients who received statins ... having Barrett,s esophagus compared to non-users," said study author ...
(Date:7/23/2014)... According to a new market research ... (Integrated Circuit IP, SOC IP), Design Architecture (Hard IP, ... Verification IP - Forecast & Analysis to 2013 - ... grow at a CAGR of 12.6% from 2014 to ... more than 76 market data tables with 60 figures ...
(Date:7/23/2014)... women has identified three genetic changes linked to an ... Vanderbilt University investigators, was published online July 20 in ... one of the most common malignancies among women worldwide, ... disease have focused on women of European ancestry. , ... between East Asian women and those of European ancestry, ...
Breaking Medicine News(10 mins):Health News:Europe Vitamins (Nutraceuticals) Market is Expected to Reach $1,202.08 Million in 2018 - New Report by MicroMarket Monitor 2Health News:Europe Vitamins (Nutraceuticals) Market is Expected to Reach $1,202.08 Million in 2018 - New Report by MicroMarket Monitor 3Health News:Europe Vitamins (Nutraceuticals) Market is Expected to Reach $1,202.08 Million in 2018 - New Report by MicroMarket Monitor 4Health News:Europe Vitamins (Nutraceuticals) Market is Expected to Reach $1,202.08 Million in 2018 - New Report by MicroMarket Monitor 5Health News:Europe Bio Fertilizer Market is Expected to Reach $4,582.2 Million in 2017 - New Report by MicroMarket Monitor 2Health News:Europe Bio Fertilizer Market is Expected to Reach $4,582.2 Million in 2017 - New Report by MicroMarket Monitor 3Health News:Europe Bio Fertilizer Market is Expected to Reach $4,582.2 Million in 2017 - New Report by MicroMarket Monitor 4Health News:Statin use decreases the risk of Barrett's esophagus 2Health News:Semiconductor IP Market Estimated to Reach $5.63 Billion by 2020 – New Report by MarketsandMarkets 2Health News:Semiconductor IP Market Estimated to Reach $5.63 Billion by 2020 – New Report by MarketsandMarkets 3Health News:Semiconductor IP Market Estimated to Reach $5.63 Billion by 2020 – New Report by MarketsandMarkets 4Health News:Semiconductor IP Market Estimated to Reach $5.63 Billion by 2020 – New Report by MarketsandMarkets 5Health News:Semiconductor IP Market Estimated to Reach $5.63 Billion by 2020 – New Report by MarketsandMarkets 6Health News:Vanderbilt-led study identifies genes linked to breast cancer in East Asian women 2
... 3-D Virtual Reality PTSD Combat Simulator -ELK GROVE VILLAGE, ... (IDVA) Director Tammy Duckworth presented the Alexian Brothers Hospital ... on Monday, February 2, at Alexian Brothers Medical Center, ... Alexian Brothers provide advanced diagnostic and treatment services to ...
... Imaging Technologies (HeartIT(R)) today publicly announced the world,s first ... medical images using nothing but a standard web browser, ... to someone halfway around the world allowing them to ... Reed, HeartIT,s Vice President for Sales and Marketing. "And ...
... decline in two-thirds of the country, , , TUESDAY, Feb. 3 ... nearly two-thirds of the states, according to a new study ... The CDC,s data analysis showed that mammography use increased slightly ... Tennessee, Georgia and Alabama. But it fell by 0.3 to ...
... at The University of Nottingham has been awarded a ... molecular biology of hepatitis C virus. , Dr Catherine ... more than 1 million in funding over five years ... and Biological Sciences Research Council (BBSRC). , Dr Jopling ...
... Arobella Medical, LLC, today announced,the achievement of ... test, and delivery of medical devices. This ... (ISO), is the,regulatory standard for the international ... 9000 and EN 46000. Receiving the ...
... . , This minimally invasive procedure, pioneering ... surgeons at the University Hospital of Navarra, which brings ... , The results obtained in patients were recently published ... Annals of Surgery . It is the highest ...
Cached Medicine News:Health News:Illinois Department of Veterans' Affairs Presents $97,500 Veteran's Cash Grant to Alexian Brothers Hospital Network 2Health News:World's First Website for Patients to Share Diagnostic-Quality Medical Images 2Health News:Fewer Women Are Having Mammograms 2Health News:Prestigious fellowship for young Nottingham researcher 2Health News:Arobella Medical Achieves ISO 13485 Medical Device Certification 2Health News:Surgical technique in Spain enables extirpation of benign tumors of the pancreas 2
Keeler Professional Combi Retinoscope with new slimline handle and lithium or dry cell option....
300XL System, English (U.K. cord), 100-240 VAC....
Micro-mini fiber optic light....
Xenon technology achieves a higher efficiency than halogen light sources. Consequently they provide more light....
Medicine Products: